The quality of reporting of cohort studies published in the most prestigious scientific medical journals was in vestigated to indicate to what extent the items in the Strength ening the Reporting of Observational Studies in Epidemiology (STROBE) checklist are addressed. Six top scientific medical journals with high impact factor were selected including New England Journal of Medicine, Journal of the American Medical Associa tion, Lan cet, British Medical Journal, Archive of Internal Medicine, and Canadian Medical Association Journal. Ten co hort studies published in 2010 were selected randomly from each journal. The percentage of items in the STR OBE checklist that were addressed in each study was investigated. The total percentage of items addressed by these studies was 69.3 (95% confidence interval: 59.6 to 79.0). We concluded that reporting of cohort studies published in the most prestigious scientific medical journals is not clear enough yet. The reporting of other types of observational studies such as casecontrol and crosssectional studies particularly those being published in less prestigious journals expected to be much more imprecise.
INTRODUCTION
Randomized trials are generally considered the gold standard for evaluating both the efficacy and the potential side effects of new therapeutic or preventive interventions in both clinical medicine and public health [1] . However, much of the biomedi cal research into the cause of diseases comes from observation al studies [2] . The results of these studies should be reported as [3] . Unfortunately, reporting of observa tional research is neither precise nor clear enough to assess the strengths and weaknesses of the evidence [4, 5] .
transparently as possible "so that readers can follow what was planned, what was done, what was found, and what conclusions were drawn"
To improve the reporting of observational research, a group of experts developed a checklist of items known as the Strength ening the Reporting of Observational Studies in Epidemiology (STROBE) statement [6] . The STROBE statement was devel oped in 2007 to assist authors in report writing of observational studies, including cohort, casecontrol, and crosssectional stud ies, to support editors and reviewers in considering such manu script for publication, and to help readers in appraising published articles critically [3] .
Concerning valuable recommendations made in this state ment, expected that reporting of observational studies publish ed after 2007 being improved enough to assess the strengths and weaknesses of the evidence. The present study was set up to investigate the quality of reporting of cohort studies pub lished in the most prestigious scientific medical journals and to indicate to what extent the items in STROBE checklist are no ticed by both authors and publishers.
METHODS
We conducted a crosssectional study and selected six top sci entific medical journals with high impact factor (IF) among the most prestigious and important medical journals indexed in in ternational databases. Among the observational studies, cohort studies are much more expensive and take longer followup time than casecon trol and crosssectional studies. Therefore, the results obtained from cohort studies are of substantially superior quality to oth er observational studies. In fact, cohort studies are considered the gold standard in observational epidemiology. Accordingly, we selected cohort studies, either prospective or retrospective, for this evaluation.
We randomly selected 10 cohort studies published in each of the six medical journals from January to August 2010. To do so, we sorted the articles from newly published articles to the old ones. Then, looked for the cohort studies to find ten eligible ar ticles. If there were not enough cohort studies, we searched se cond half of 2009 to obtain additional studies. Accordingly, we enrolled 60 cohort studies from six prestigious scientific medi cal journals. The studies were randomly assigned to four review ers through drawing lots. The reviewers independently made the decisions on the number of items, from the STROBE check list, which were addressed in the selected studies. The reviewers were not blinded to the names of the studies' authors and jour nals.
In order to check the reliability of the four reviewers' judg ment on the quality of reporting of cohort studies, we conduct ed two consecutive pilot studies as follows. First, an article was randomly selected from JAMA. All four reviewers assessed the strengths and weaknesses of the evidence reported in the same article using the predetermined checklist of items. The disagree ments were discussed to reach the same perception of the check list in order to increase the between reviewers reliability. Then, the four reviewers evaluated the quality of reporting of another article that was randomly selected. There was no significant dif ferences between the reviewers' judgment in the second pilot study (p= 0.823).
In order to assess the validity of the reviewers' judgments, two reviewers made decision on the quality of reporting of each co hort study independently. Any disagreements were resolved by adjudication with a third author.
The STROBE statement included a checklist of 22 items. In order to estimate the quality of reporting of cohort studies more accurately, we divided the items into 47 subitems (Table 1) . We considered three choices for each subitem (reported/not re ported/not applicable). The percentage of each subitem addre ssed in the selected articles was estimated. The total percentage for all subitems was reported.
All statistical analysis was performed at 95% significant level using statistical software Stata version 10.0 (StataCorp, College Station, TX, USA).
RESULTS
In this survey, 60 cohort studies were selected for evaluation including 10 studies from the six prestigious scientific medical journals including: N Engl J Med, JAMA, Lancet, BMJ, Arch In tern Med, and Can Med Assoc J. From these, 56 studies were published in 2010 and four studies in 2009. The percentage of items and subitems addressed by these studies are summarized in Table 1 . The subitems were not applicable in 7.1% (95% con fidence interval [CI], 1.3% to 13.0%), were not reported in 23.6% (95% CI, 15.3% to 31.5%), and were reported in 69.3% (95% CI, 59.6% to 79.0%) of the cohort studies.
Of 47 subitems investigated in this survey, nine subitems were reported 100%, 22 subitems were addressed in more than 90% of the studies, 28 subitems were included in more than 75% of the studies, and 32 subitems were addressed in more than 50% of the studies.
DISCUSSION
STROBE checklist of items provides valuable recommenda tions for both authors to report the results of observational stu dies clearly as well as for editors, reviewers, and readers to ap praise such reports critically [3] . On overall, almost 69.3% of the items and subitems in STROBE checklist were addressed by cohort studies published in six top scientific medical journals three year after dissemination of STROBE statement.
However, what has happened to the reports of other types of observational studies? The results of the present study represent the reporting of cohort studies published in six prestigious sci entific medical journals that generally accept the welldone and wellwritten studies. However, there are numerous observation al studies, the results of which are published in other less fastid Give matching criteria 54 ( Give confounder-adjusted estimates 1 (1. ious peerreviewed medical journals. Thus, it is expected that the quality of reporting of such studies is much poorer than what reported in the present study, although the result of present study is not desirable enough. Furthermore, cohort studies are much more expensive and take longer followup time than oth er types of observational studies such as casecontrol and cross sectional design. Hence, the reporting of cohort studies is gen erally expected to be of substantially superior quality to other observational studies. Accordingly, if this survey had been plan n ed to assess reporting of casecontrol or crosssectional studies, the estimated result would be much more undesirable. We found no similar studies but one. Poorolajal et al. [7] con ducted a similar study in 2007 to assess the reporting of cohort studies before STROBE statement being issued. However, the design, the results, and the number of subitems, which were evaluated in that study, was not comparable with that of the pre sent study.
The present study had a number of limitations. First, the lim ited number of studies evaluated in the present study may in crease the possibility of random error. Second, randomly selec tion of cohort studies from a few prestigious medical journals may increase the possibility of selection bias. Third, the value of all subitems was not really the same. Hence, adding up all per centages to estimate a summary measure might not be reason able, although was done to help the readers make an overall judgment.
This result of the present survey represents the quality of the reporting of cohort studies in top scientific medical journals. Hence, we can generalize the results of this survey neither to other types of observational studies nor to the publication of less fastidious peerreviewed medical journals.
We concluded that reporting of cohort studies published in the most prestigious scientific medical journals is not clear and desirable enough yet. The reporting of other types of observa tional studies such as casecontrol and crosssectional studies particularly those being published in less fastidious peerreview ed journals is expected to be much more imprecise. This issue should be the focus of the both authors' and editors' special at tention when reporting and/or reviewing the reports of obser vational studies.
